Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Method and apparatus for networked modems
Client-managed group communication sessions within a wireless communications system
Electronic component, a semiconductor wafer and a method for producing an electronic component
Adaptive control for uncertain nonlinear multi-input multi-output systems
Authenticating and off-loading IPTV operations from mobile devices to fixed rendering viewing devices
Apparatus and method for extracting cascading style sheet rules
Vectorization of program code
  Randomly Featured Patents
Latch circuit and register circuit
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate
Conformationally constrained backbone cyclized peptide analogs
LCD television
Transseptal puncture needles and needle assemblies
Motor vehicle seat with adjustable seat depth
Gate driver for thyristor
Key for locking cylinders, particularly for locking systems
Knife for peeling of tropical fruits
System including bar coded wristband